SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-308488
Filing Date
2014-08-13
Accepted
2014-08-13 16:38:24
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d747230d10q.htm 10-Q 291702
2 EX-31.1 d747230dex311.htm EX-31.1 8616
3 EX-31.2 d747230dex312.htm EX-31.2 8595
4 EX-32.1 d747230dex321.htm EX-32.1 3479
5 EX-32.2 d747230dex322.htm EX-32.2 3462
  Complete submission text file 0001193125-14-308488.txt   3091713

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20140630.xml EX-101.INS 412219
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20140630.xsd EX-101.SCH 38449
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20140630_cal.xml EX-101.CAL 45416
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20140630_def.xml EX-101.DEF 102098
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20140630_lab.xml EX-101.LAB 275876
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20140630_pre.xml EX-101.PRE 185549
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 141037981
SIC: 2834 Pharmaceutical Preparations